FEATURES OF THE CLINICAL COURSE OF ADENOMYOSIS AFTER THE EXPERIENCED DISEASE OF COVID–19
DOI:
https://doi.org/10.11603/24116-4944.2022.2.13455Keywords:
features, clinical course, adenomyosis, COVID-19Abstract
The aim of the study – to study the clinical features of the course of adenomyosis in women of reproductive age 3 months after suffering from the COVID-19 disease.
Materials and Methods. 30 women of reproductive age (24–40 years old), patients with diffuse adenomyosis of the I–IV degree, 3 months after suffering from the COVID-19 disease of varying degrees of severity, were examined. The clinical course of adenomyosis, the results of laboratory indicators were analyzed
Results and Discussion. The average duration of adenomyosis from the moment of diagnosis was 7±1 years. Combined pathology occurred in 100 % of patients. Patients with adenomyosis are characterized by polymorbidity, frequent exacerbations of extragenital diseases, and polypharmacy. Gynecological pathology is represented by infectious processes of the vagina, cervix, leiomyoma, menstrual dysfunction. Diffuse adenomyosis was clinically manifested by heavy menstrual bleeding, dysmenorrhea, pelvic and headache pains, nausea, indigestion, and frequent urination. There were increased levels of platelets, monocytes, ESR, fibrinogen, D-dimer, and decreased levels of hemoglobin, erythrocytes, lymphocytes, ferritin, vitamin D. SARSCov-2 (COVID-19) IgG antibodies (positive rate) were detected in 100% of women within 1.84 – 1.90.
Conclusions. Features of the clinical course of the diffuse form of adenomyosis of the I–IV degree of severity in women of reproductive age after suffering from the disease of COVID-19 consist in the activation of the symptoms of the main disease, progressive anemization of the body, and an increase in the thrombotic activity of the blood. The presented complications are a rationale for determining the personalized tactics of managing patients after a disease.
References
Honcharenko, H.Yu. (2019). Rol estrohenovykh i prohesteronovykh retseptoriv u zhinok z adenomiozom u postmenopauzi [The role of estrogen and progesterone receptors in postmenopausal women with adenomyosis]. Visnyk Vinnytskoho natsionalnoho medychnoho universytetu – Bulletin of Vinnytsia National Medical University, 23, 148-152. DOI: 10/31393/reports–vnmedical –2019–23(1)–26 [in Ukrainian].
Potapov, V.O. (2021). Adenomioz: problemni pytannya likuvannya, [Adenomyosis: problematic issues of treatment]. Akusherstvo, Hinekolohiya, Reproduktolohiya – Obstetrics, Gynecology, Reproduction, 2(43). Retrieved from: health–ua.com/article/65800–adenomioz–problemn–pitanny–likuvannya [in Ukrainian].
Andreev, T.S., Kleimenova, A.O., Drobintseva, VO., & Polyakova, I.M. (2019). Signal molecules in volved in the fermatio of new nerve end ingsin endometriosis (literature review.). Swing Scientific Results of Biomedical Research, 5.1, 94-107.
Ahmed, S., Zimba, O., & Gasparyan, A.Y. (2020). Thrombosis in Coronavirus disease 2019 (COVID–19) through the prism of Virchow’s triad. Clin. Rheumatol., 39, 2529-2543. DOI: 10.1007/s10067–020–05275–1.
Brandon, M.H., Vikse, J., Benoit, S., Favaloro, E.J., & Lippi, G. (2020). Hyperinflammation and derangement of renin–angiotensin–aldosterone system in COVID–19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin. Chim. Acta., 507, 167-173. DOI: 10.1016/j.cca.2020.04.027.
COVID–19 rapid guideline: managing the long–term effects of COVID–19. NICE guideline [NG 188] Published date, 18 December 2020. Retrieved from: htts://www.nice.org.uk/guidance/ng188.
Bobritskaya, V.V., & Chernyak, O.L. (2018). Elimination of endothelial dysfunction in the pathogeenec mechanism of infertility. Obstetrics Gynecology Genetics, 4.2, 31-38.
Cuevas, M., Cruz, M.L., Ramirez, A.R. , Flores, I., Thompson, K.J., Bayona, M., Vernon, M.W., & Appleyard, C.B. (2018). Stress During Development of Experimental Endometriosis Influences Nerve Growth and Disease Progression. Reprod. Sci., 25(3), 347-357. DOI: 10.1177/1933719117737846. Epub 2017 Nov 6.
Harmsen, M.J., Wong, C.F.C., Mijatovic, V., Griffioen, A.W., Groenman, F., Hehenkamp, W.J.K., Judith, A.F., & Huirne J.A.F. (2019). Role of angiogenesis in adenomyosis–associated abnormal uterine bleeding and subfertility: a systematic review. Hum. Reprod. Update., 11, 25(5), 647-671. DOI: 10.1093/humupd/dmz024.
Yang, B., Wang, L., Wan, X., Li, Y., Yu, X., Qin, Y., Luo, Y., ... Huang, O. (2017). Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis. BMC Womens Health, 17(1), 118. DOI: 10.1186/s12905–017–0474–z.
Van den Bosch, T., de Bruijn, A.M., de Leeuw, R.A. , Dueholm, M., Exacoustos, C., Valentin, L., Bourne,T., ... Huirne, J.A.F. (2019). Sonographic classification and reporting system for diagnosing adenomyosis. Ultrasound Obstet. Gynecol., 53(5), 576-582. DOI: 10.1002/uog.19096.
De Bruijn, A.M., Smink, M., Hehenkamp, W.J.K., Nijenhuis, R.J., Smeets, A.J., Boekkooi, F., Reuwer, P.J.H.M., ... Lohle, P.N.M. (2017). Uterine Artery Embolization for Symptomatic Adenomyosis: 7–Year Clinical Follow–up Using UFS–Qol Questionnaire. Cardiovasc. Intervent. Radiol., 40(9), 1344–1350. DOI: 10.1007/s00270–017–1686–1. Epub 2017 May 17.
Pontis, A., D'Alterio, M.N. , Pirarba, S. , de Angelis, C. , Tinelli, R., & Angioni, S. (2016). Adenomyosis: a systematic review of medical treatment . Gynecol. Endocrinol., 32(9), 696-700. DOI: 10.1080/09513590.2016.1197200. Epub 2016 Jul 5.
Gustafson, D., Raju, S., Wu, R., Ching, C., Veitch, Sh., Rathnakumar, K., Boudreau, E., ... Fish, J.E. (2020). Overcoming Barriers: The Endothelium As a Linchpin of Coronavirus Disease 2019 Pathogenesis? Arterioscler. Thromb. Vasc. Biol., 40(8), 1818-1829. DOI: 10.1161/ATVBAHA.120.314558.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Actual Problems of Pediatrics, Obstetrics and Gynecology
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).
